2.75
price down icon3.51%   -0.10
pre-market  Pre-market:  2.75  
loading

Sonoma Pharmaceuticals Inc Stock (SNOA) Forecast

The Sonoma Pharmaceuticals Inc (SNOA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.8381, representing a +3.20% increase from the current price of $2.75. The highest analyst price target is $3.8153, and the lowest is $1.8609.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SNOA Price Target
Average 4.9769 (+80.98% Upside)
loading

Is Sonoma Pharmaceuticals Inc (SNOA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 22.53 Buy
STOCH(9,6) 11.19 Buy
STOCHRSI(14) 3.264 Buy
MACD(12,26) -0.1734 Sell
ADX(14) 26.43 Sell
William %R -92.25 Buy
CCI(14) -141.58 Sell
Buy: 4 Sell: 3 Neutral: 0
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
3.033
Sell
2.9964
Sell
MA20
3.1935
Sell
3.1492
Sell
MA50
3.4119
Sell
3.3573
Sell
MA100
3.6044
Sell
3.4946
Sell
MA200
3.6116
Sell
3.4532
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, SNOA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on SNOA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 22.53 indicates that SNOA is oversold. This indicates that SNOA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 11.19 indicates that SNOA is oversold. This indicates that SNOA price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.264 indicates that SNOA is oversold. This suggests that SNOA price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 26.43 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -141.58 indicates that SNOA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term SNOA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Sonoma Pharmaceuticals Inc financial reports and earnings history, Sonoma Pharmaceuticals Inc (SNOA) stock could reach $7.75 by 2030, $4.4127 by 2040 and $14.33 by 2050. See the projected annual prices until 2050 of the Sonoma Pharmaceuticals Inc stock below:

  • Sonoma Pharmaceuticals Inc (SNOA) is expected to reach an average price of $1.564 in 2035, with a high prediction of $1.7388 and a low estimate of $1.5938. This indicates an $-43.13% rise from the last recorded price of $2.75.
  • Sonoma Pharmaceuticals Inc (SNOA) stock is projected to chart a bullish course in 2040, with an average price target of $4.264, representing an $55.06% surge from its current level. The forecast ranges from a conservative $4.2723 to a sky-high $4.4127.
  • Our analysts predict Sonoma Pharmaceuticals Inc (SNOA) to jump 200.33% by 2045, soaring from $7.7992 to an average price of $8.2591, potentially reaching $8.1915. While $7.7992 is the low estimate, the potential upside is significant.
  • Sonoma Pharmaceuticals Inc (SNOA) stock is expected to climb by 2050, reaching an average of $14.04, a $410.38% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.33 and $14.44, respectively, highlighting the market's uncertainty.

Sonoma Pharmaceuticals Inc Stock (SNOA) Year by Year Forecast

Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2026

The predicted value for Sonoma Pharmaceuticals Inc (SNOA) in 2026 is set at an average of $5.2991. Estimates vary from a peak of $9.8941 to a trough of $0.7041, indicating an +92.69% surge from the present price of $2.75.
Month Average Low High Change from today's price
March, 2026 $3.2521 $1.8609 $3.8153 +18.26%
April, 2026 $4.0601 $2.6434 $5.0287 +47.64%
May, 2026 $2.7025 $1.654 $4.3778 -1.73%
June, 2026 $3.7549 $1.7081 $5.0293 +36.54%
July, 2026 $2.4229 $2.3929 $4.5673 -11.90%
August, 2026 $3.3453 $2.4185 $3.6652 +21.65%
September, 2026 $2.7933 $2.4333 $3.6321 +1.57%
October, 2026 $1.2957 $0.9345 $5.2789 -52.88%
November, 2026 $2.0681 $0.9169 $9.0369 -24.80%
December, 2026 $1.4361 $0.9805 $4.6161 -47.78%

Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Sonoma Pharmaceuticals Inc (SNOA) is $1.568, with a high forecast of $3.1329 and a low forecast of $0.0031. This indicates an -42.98% decrease from the last price of $2.75.
Month Average Low High Change from today's price
January, 2027 $1.5085 $1.1173 $3.1329 -45.15%
February, 2027 $1.5809 $1.2709 $2.7753 -42.51%
March, 2027 $0.9989 $0.3634 $1.6465 -63.68%
April, 2027 $0.8913 $0.5313 $1.2201 -67.59%
May, 2027 $0.3087 $0.0031 $0.9069 -88.77%
June, 2027 $0.5283 $0.1393 $0.4493 -80.79%
July, 2027 $0.6341 $0.2259 $0.7641 -76.94%
August, 2027 $0.4635 $0.1247 $0.6397 -83.15%
September, 2027 $0.2245 $0.0545 $1.0789 -91.84%
October, 2027 $0.0269 $0.1017 $0.5457 -99.02%
November, 2027 $0.0293 $0.0819 $0.1427 -98.93%
December, 2027 $0.4703 $0.0739 $1.3517 -82.90%

Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2028

In 2028, Sonoma Pharmaceuticals Inc (SNOA) is projected to reach an average price of $0.5571, with a high projection of $1.0739 and a low estimate of $0.0403. This indicates an -79.74% fall from the last price of $2.75.
Month Average Low High Change from today's price
January, 2028 $0.0997 $0.0403 $0.6829 -96.37%
February, 2028 $0.4779 $0.0453 $0.3679 -82.62%
March, 2028 $0.4899 $0.5223 $0.4691 -82.19%
April, 2028 $0.5775 $0.4931 $0.8857 -79.00%
May, 2028 $1.0995 $0.6963 $0.9195 -60.02%
June, 2028 $0.9171 $0.9871 $1.0739 -66.65%
July, 2028 $0.5047 $0.4459 $0.5585 -81.65%
August, 2028 $0.9566 $0.5879 $0.7466 -65.21%
September, 2028 $0.8742 $0.8936 $0.8291 -68.21%
October, 2028 $0.7418 $0.7918 $0.7286 -73.02%
November, 2028 $0.617 $0.6537 $0.6457 -77.56%
December, 2028 $0.4114 $0.3326 $0.3314 -85.04%

Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2029

The 2029 price forecast for Sonoma Pharmaceuticals Inc Stock (SNOA) is $3.6837 on average, with a high prediction of $7.3436 and a low estimate of $0.0238. This represents an +33.95% increase from the previous price of $2.75.
Month Average Low High Change from today's price
January, 2029 $0.2734 $0.2734 $0.3258 -90.06%
February, 2029 $0.406 $0.3405 $0.361 -85.24%
March, 2029 $0.2008 $0.2542 $0.2954 -92.70%
April, 2029 $0.2762 $0.3442 $0.2969 -89.96%
May, 2029 $0.7776 $0.4356 $0.7694 -71.72%
June, 2029 $0.6408 $0.6503 $0.7207 -76.70%
July, 2029 $0.533 $0.5517 $0.5758 -80.62%
August, 2029 $0.4003 $0.4432 $0.4942 -85.44%
September, 2029 $0.337 $0.339 $0.3747 -87.75%
October, 2029 $0.214 $0.2239 $0.2997 -92.22%
November, 2029 $0.1026 $0.1046 $0.1388 -96.27%
December, 2029 $7.5236 $0.0238 $7.3436 +173.59%

Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2030

Sonoma Pharmaceuticals Inc Stock (SNOA) is expected to reach an average price of $8.439 in 2030, with a high forecast of $9.344 and a low forecast of $7.534. This signifies an +206.87% surge from the last price of $2.75.
Month Average Low High Change from today's price
January, 2030 $8.2756 $7.9073 $7.75 +200.93%
February, 2030 $8.1528 $7.534 $7.3928 +196.47%
March, 2030 $8.568 $8.5904 $8.388 +211.56%
April, 2030 $7.6832 $8.2432 $8.6356 +179.39%
May, 2030 $8.4672 $8.2096 $7.9172 +207.90%
June, 2030 $8.9524 $9.0124 $8.9301 +225.54%
July, 2030 $8.7664 $7.8024 $7.7764 +218.78%
August, 2030 $9.5416 $9.5616 $9.344 +246.97%
September, 2030 $9.1367 $9.1079 $9.0392 +232.25%
October, 2030 $8.0521 $8.1007 $8.0955 +192.81%
November, 2030 $8.0659 $7.9471 $7.3083 +193.31%
December, 2030 $7.6845 $8.0323 $7.4347 +179.44%
drug_manufacturers_specialty_generic RDY
$14.31
price up icon 0.70%
$123.10
price down icon 10.43%
$24.79
price down icon 3.58%
drug_manufacturers_specialty_generic RGC
$29.02
price up icon 8.61%
$15.79
price down icon 2.11%
$476.13
price up icon 0.06%
Cap:     |  Volume (24h):